
Semaglutide Research
Tirzepatide is a dual GIP and GLP-1 receptor agonist used for the management of type 2 diabetes and, in approved indications, chronic weight management. Clinical studies have shown meaningful improvements in blood glucose control and body weight. However, treatment response may vary, and side effects or contraindications may occur. Tirzepatide should only be used under the guidance of a qualified healthcare professional, with appropriate assessment and ongoing monitoring.


























